Profil
Yu Xiong currently works at UKDE Ltd., as Co-Chairman & Chair-Management Board and 3D Bio-Tissues Ltd., as Director.
Postes actifs de Yu Xiong
| Sociétés | Poste | Début |
|---|---|---|
3D Bio-Tissues Ltd.
 3D Bio-Tissues Ltd. BiotechnologyHealth Technology Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million. | Directeur/Membre du Conseil | - |
UKDE Ltd.
 UKDE Ltd. Packaged SoftwareTechnology Services UKDE Ltd. provides digital finance and blockchain technology services. The private company is based in London, UK. The British company was founded in 2018 by Guoyu Du. The CEO is Yu Xiong. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
UKDE Ltd.
UKDE Ltd. Packaged SoftwareTechnology Services UKDE Ltd. provides digital finance and blockchain technology services. The private company is based in London, UK. The British company was founded in 2018 by Guoyu Du. The CEO is Yu Xiong. | Technology Services |
3D Bio-Tissues Ltd.
3D Bio-Tissues Ltd. BiotechnologyHealth Technology Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million. | Health Technology |